OptimizeRx Corporation Common Stock
OPRXUnited States
5 filed reports · 284 financial concepts · 4 earnings calls · 0 media appearances
Filed reports
5 reports · Jun 2025 to Jun 2026Each report counts once it has at least one extracted financial fact.
| Report type | Reports | Facts | Periods |
|---|---|---|---|
| Quarterly · 10-QSEC EDGAR | 4 | 872 | Jun 2025 to Jun 2026 |
| Annual · 10-KSEC EDGAR | 1 | 642 | Dec 2025 |
Financial data
284 concepts · 1,514 factsEach concept is one reported line item or metric. The count is how many values of it are held, across the periods shown.
Financial283 concepts · 1,510 facts · Dec 2010 to Jun 2026
- Adjustments to additional paid in capital share based compensation restricted stock units requisite service period recognition12 · Mar 2024 to Jun 2026
- Adjustments to additional paid in capital share based compensation stock options requisite service period recognition12 · Mar 2024 to Jun 2026
- Allowance for doubtful accounts receivable current12 · Mar 2024 to Jun 2026
- Allowance for doubtful accounts receivable write offs12 · Mar 2024 to Jun 2026
- Amount collected12 · Mar 2024 to Jun 2026
- Contract with customer liability current12 · Mar 2024 to Jun 2026
- Net income loss12 · Mar 2024 to Jun 2026
- Provision for doubtful accounts12 · Mar 2024 to Jun 2026
- Revenue recognized12 · Mar 2024 to Jun 2026
- Stockholders equity (US GAAP)12 · Mar 2024 to Jun 2026
- Stock issued during period value restricted stock award net of forfeitures12 · Mar 2024 to Jun 2026
- Amortization of financing costs11 · Jun 2024 to Jun 2026
- Cash cash equivalents restricted cash and restricted cash equivalents11 · Jun 2024 to Jun 2026
- Cost of revenue (US GAAP)11 · Jun 2024 to Jun 2026
- Depreciation and amortization11 · Jun 2024 to Jun 2026
- Income tax expense benefit11 · Jun 2024 to Jun 2026
- Interest expense nonoperating11 · Jun 2024 to Jun 2026
- Investment income interest11 · Jun 2024 to Jun 2026
- Lease cost11 · Jun 2024 to Jun 2026
- Nonoperating income expense11 · Jun 2024 to Jun 2026
- Operating income loss11 · Jun 2024 to Jun 2026
- Operating lease cost11 · Jun 2024 to Jun 2026
- Other nonoperating income11 · Jun 2024 to Jun 2026
- Preferred stock shares issued11 · Jun 2024 to Jun 2026
Product1 concepts · 4 facts · Dec 2024 to Dec 2025
- Revenue4 · Dec 2024 to Dec 2025
Segments
4 factsFigures broken down by business line, region, product or another axis the company reports on.
Product or service2 members · 4 facts
- Life Science Companies2 · Dec 2024 to Dec 2025
- Other Revenue2 · Dec 2024 to Dec 2025
Text from filings
Management commentary and risk factors, extracted from SEC filings only.
No commentary or risk-factor text for this company.
Earnings calls
4 calls · Nov 2025 to Aug 2026Transcripts with management claims and analyst questions, one per fiscal period.
- FY2026 Q2Aug 12, 2026
- FY2026 Q1May 12, 2026
- FY2025 Q4Mar 5, 2026
- FY2025 Q3Nov 7, 2025
Executive media
Podcasts, interviews and conference appearances by the company's executives, with their claims.
No media appearances for this company.
Reports are counted as filed reports with at least one served fact. Counts are read from the database (last read Oct 17, 2026) and refreshed every few hours.